Invesco’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.6M | Buy |
928,501
+101,978
| +12% | +$4.13M | 0.01% | 1174 |
|
|
2025
Q1 | $42.5M | Sell |
826,523
-105,592
| -11% | -$5.42M | 0.01% | 1104 |
|
|
2024
Q4 | $51.6M | Buy |
932,115
+250,018
| +37% | +$13.8M | 0.01% | 1026 |
|
|
2024
Q3 | $22.4M | Buy |
682,097
+290,534
| +74% | +$9.56M | ﹤0.01% | 1415 |
|
|
2024
Q2 | $10.6M | Buy |
391,563
+167,994
| +75% | +$4.57M | ﹤0.01% | 1755 |
|
|
2024
Q1 | $8.13M | Buy |
223,569
+125,696
| +128% | +$4.57M | ﹤0.01% | 1935 |
|
|
2023
Q4 | $1.98M | Buy |
+97,873
| New | +$1.98M | ﹤0.01% | 2609 |
|
|
2023
Q3 | – | Sell |
-41,769
| Closed | -$755K | – | 3893 |
|
|
2023
Q2 | $755K | Sell |
41,769
-19,409
| -32% | -$351K | ﹤0.01% | 3012 |
|
|
2023
Q1 | $769K | Buy |
61,178
+4,444
| +8% | +$55.9K | ﹤0.01% | 3020 |
|
|
2022
Q4 | $832K | Buy |
56,734
+16,071
| +40% | +$236K | ﹤0.01% | 3003 |
|
|
2022
Q3 | $696K | Sell |
40,663
-1,954
| -5% | -$33.4K | ﹤0.01% | 3054 |
|
|
2022
Q2 | $622K | Buy |
42,617
+14,635
| +52% | +$214K | ﹤0.01% | 3211 |
|
|
2022
Q1 | $471K | Buy |
27,982
+4,078
| +17% | +$68.6K | ﹤0.01% | 3388 |
|
|
2021
Q4 | $538K | Sell |
23,904
-4,710
| -16% | -$106K | ﹤0.01% | 3324 |
|
|
2021
Q3 | $616K | Sell |
28,614
-1,814
| -6% | -$39.1K | ﹤0.01% | 3304 |
|
|
2021
Q2 | $882K | Buy |
30,428
+1,169
| +4% | +$33.9K | ﹤0.01% | 3156 |
|
|
2021
Q1 | $943K | Buy |
29,259
+9,892
| +51% | +$319K | ﹤0.01% | 3050 |
|
|
2020
Q4 | $801K | Buy |
+19,367
| New | +$801K | ﹤0.01% | 3019 |
|